Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme

Temozolomide (tmz) is an oral alkylating agent used during concurrent and adjuvant chemotherapy for newly diagnosed glioblastoma multiforme. Temozolomide is generally well tolerated and improves survival; however, severe adverse events have occasionally been reported. Here, we report the case of a p...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Oh, J., Kutas, G.J., Davey, P., Morrison, M., Perry, J.R.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2010
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913822/
https://ncbi.nlm.nih.gov/pubmed/20697524
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky